California drug makers are using their monopoly power

California drug makers are using their monopoly power

California drug makers are using their monopoly power against the people of California. Right now, these corporations have free rein to hike up drug prices at a moment’s notice and keep drug purchasing data secret, leaving Californians in the dark.

But we are fighting back.

Sen. Hernandez has introduced Senate Bill 17, which will hold drug makers accountable by demanding greater transparency. This bill has already made it through the state Senate, and the Assembly is considering the measure right now.

Senate Bill 17 will:

  • Require drug makers to publish data about purchasing trends, including drug prescription and pricing data.
  • Prevent drug companies from dramatically raising prices without warning by requiring drug companies to give 60 days’ notice to purchasers before making major increases to drug prices.
  • Require health insurance companies to disclose what portion of premiums go towards prescription drugs.

This legislation will empower purchasers to make cost-effective health care decisions based off newly-available information pharmaceutical companies have to provide. With more transparency, SB 17 will help keep costs down for Californians.

Act Now: Write your state assemblymember and urge them to support Senate Bill 17.

ACT NOW >> 

Thanks for taking a stand,

http://sign.actiontaker.org/Support-Senate-Bill-17

— NextGen America

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s